Purification of coagulation factor VIII using chromatographic methods. Direct chromatography of plasma in anion exchange resins

Coagulation factor VIII (FVIII) concentrates are used in the treatment of patients with Hemophilia A. Human FVIII was purified directly from plasma using anion exchange chromatography followed by gel filtration. Three Q-Sepharose resins were tested, resulting in 40% recovery of FVIII activity using...

Full description

Saved in:
Bibliographic Details
Published inBiotechnology letters Vol. 32; no. 9; pp. 1207 - 1214
Main Authors Cheng, Elisabeth, Jinzenji, Daniela, Lorthiois, Ana Paula Almeida Aranha, de Carvalho, Roberta Rodrigues, Tanaka-Azevedo, Anita Mitiko, Raw, Isaías, Martins, Elizabeth Angélica Leme
Format Journal Article
LanguageEnglish
Published Dordrecht Dordrecht : Springer Netherlands 01.09.2010
Springer Netherlands
Springer
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Coagulation factor VIII (FVIII) concentrates are used in the treatment of patients with Hemophilia A. Human FVIII was purified directly from plasma using anion exchange chromatography followed by gel filtration. Three Q-Sepharose resins were tested, resulting in 40% recovery of FVIII activity using Q-Sepharose XL resin, about 80% using Q-Sepharose Fast Flow and 70% using the Q-Sepharose Big Beads. The vitamin K-dependent coagulation factors co-eluted with FVIII from the anion exchange columns. In the second step of purification, when Sepharose 6FF was used, 70% of FVIII activity was recovered free from vitamin K-dependent factors.
Bibliography:http://dx.doi.org/10.1007/s10529-010-0282-0
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0141-5492
1573-6776
DOI:10.1007/s10529-010-0282-0